サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1647361

ヘルスケアアナリティクス市場：コンポーネント別、タイプ別、用途別、エンドユーザー別、地域別 - 2029年までの予測

Healthcare Analytics Market by Type, Application, EndUser, & Region: Global Forecast to 2029

出版日
ページ情報
英文 411 Pages
納期
即納可能 即納可能とは
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=147.66円
ヘルスケアアナリティクス市場：コンポーネント別、タイプ別、用途別、エンドユーザー別、地域別 - 2029年までの予測
出版日: 2025年01月01日
発行: MarketsandMarkets
ページ情報: 英文 411 Pages
納期: 即納可能 即納可能とは
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界のヘルスケアアナリティクスの市場規模は、2024年の448億3,000万米ドルから2029年には1,331億9,000万米ドルに達すると予測され、2024年から2029年までのCAGRは24.3%になるとみられています。

電子カルテ（EHR）の普及がヘルスケアアナリティクス市場の成長を加速させています。北米では、約78%の勤務医と96%の非連邦急性期病院がEHRシステムを使用しており、HITECH法などの規制優遇措置に支えられています。欧州のEHR導入率はまちまちで、オランダは97%、欧州全土の平均は81%であり、アナリティクス統合の可能性が高いことを示しています。EHRの導入が進むと、データへのアクセス性が向上し、高度な分析ソリューションの需要が高まります。

調査範囲
調査対象年 2022年～2029年
基準年 2023年
予測期間 2024年～2029年
検討単位 100万/10億（米ドル）
セグメント別 コンポーネント別、タイプ別、用途別、エンドユーザー別、地域別
対象地域 北米、欧州、アジア太平洋、ラテンアメリカ、中東アフリカ

用途別では、ヘルスケアアナリティクス市場は財務アナリティクス、臨床アナリティクス、オペレーション・管理アナリティクス、集団健康アナリティクスに区分されます。2023年には、臨床アナリティクス分野が最大の市場シェアを占めています。バリュー・ベース・ケア、技術の進歩、患者アウトカムの改善が、アウトカムに基づくパフォーマンス、コストの最適化、AIとEHRシステムによるパーソナライズされたデータ駆動型ケアの実現に注力することで、臨床アナリティクスの成長を促進しています。これにより、ケアの質と効率が向上し、ヘルスケアアナリティクス市場が活性化します。

地域別では、アジア太平洋のヘルスケアアナリティクス市場は予測期間中に最も高いCAGR率を記録すると予測されています。アジア太平洋のヘルスケアアナリティクス市場は、アジア太平洋のバイパス手術の平均費用が約4,000米ドルであるのに対し、米国では3万～20万米ドルであるなど、手ごろな価格で医療を受けられることから拡大しています。さらに、メディカルツーリズムに対する政府の支援、ヘルスケアインフラ投資、ITの拡大、慢性疾患を抱える高齢化人口の増加が、世界のヘルスケアにおける同地域の地位を総体的に強化しています。

当レポートでは、世界のヘルスケアアナリティクス市場について調査し、コンポーネント別、タイプ別、用途別、エンドユーザー別、地域別動向、および市場に参入する企業のプロファイルなどをまとめています。

目次

第1章 イントロダクション

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 重要考察

第5章 市場概要

  • イントロダクション
  • 市場力学
  • 顧客ビジネスに影響を与える動向/混乱
  • 業界動向
  • エコシステム分析
  • バリューチェーン分析
  • 技術分析
  • 規制分析
  • 価格分析
  • ポーターのファイブフォース分析
  • 特許分析
  • 主な利害関係者と購入基準
  • エンドユーザー分析
  • 2024年～2025年の主な会議とイベント
  • ケーススタディ分析
  • ビジネスモデル分析
  • 投資と資金調達のシナリオ
  • AI/生成AIがヘルスケアアナリティクス市場に与える影響

第6章 ヘルスケアアナリティクス市場（コンポーネント別）

  • イントロダクション
  • サービス
  • ソフトウェア

第7章 ヘルスケアアナリティクス市場（タイプ別）

  • イントロダクション
  • 記述的分析
  • 予測分析
  • 処方分析
  • 診断分析

第8章 ヘルスケアアナリティクス市場（用途別）

  • イントロダクション
  • 財務
  • 臨床
  • 運用および管理
  • 人口健康

第9章 ヘルスケアアナリティクス市場（エンドユーザー別）

  • イントロダクション
  • 支払者
  • プロバイダー
  • 医薬品・医療機器サプライチェーン

第10章 ヘルスケアアナリティクス市場（地域別）

  • イントロダクション
  • 北米
    • 北米のマクロ経済見通し
    • 米国
    • カナダ
  • 欧州
    • 欧州のマクロ経済見通し
    • ドイツ
    • 英国
    • フランス
    • イタリア
    • スペイン
    • その他
  • アジア太平洋
    • アジア太平洋のマクロ経済見通し
    • 日本
    • 中国
    • インド
    • その他
  • ラテンアメリカ
    • ラテンアメリカのマクロ経済見通し
    • ブラジル
    • メキシコ
    • その他
  • 中東・アフリカ
    • 中東・アフリカのマクロ経済見通し
    • GCC諸国
    • その他

第11章 競合情勢

  • イントロダクション
  • 主要参入企業の戦略/強み、2021年～2025年
  • 収益分析、2019年～2023年
  • 市場シェア分析、2023年
  • 企業評価と財務指標
  • ブランド/ソフトウェアの比較
  • 企業評価マトリックス：主要参入企業、2023年
  • 企業評価マトリックス：スタートアップ/中小企業、2023年
  • 競合シナリオ

第12章 企業プロファイル

  • 主要参入企業
    • MERATIVE
    • SAS INSTITUTE INC.
    • OPTUM, INC.
    • ORACLE
    • VERADIGM LLC
    • EXLSERVICE HOLDINGS, INC.
    • CITIUSTECH INC.
    • HEALTH CATALYST
    • CVS HEALTH
    • INOVALON
    • MCKESSON CORPORATION
    • MEDEANALYTICS, INC.
    • COTIVITI, INC.
    • APIXIO, INC.
    • ENLITIC
    • KOMODO HEALTH, INC.
    • HEALTHEC, LLC
    • IQVIA
    • WIPRO
  • その他の企業
    • ARCADIA SOLUTIONS, LLC.
    • EVIDATION HEALTH, INC.
    • HEALTHCORUM
    • AETION, INC.
    • TREDENCE.INC.
    • SISENSE LTD.

第13章 付録

図表

List of Tables

  • TABLE 1 HEALTHCARE ANALYTICS MARKET: INCLUSIONS AND EXCLUSIONS
  • TABLE 2 HEALTHCARE ANALYTICS MARKET: RESEARCH ASSUMPTIONS
  • TABLE 3 HEALTHCARE ANALYTICS MARKET: RISK ASSESSMENT
  • TABLE 4 HEALTHCARE DATA BREACHES: ENTITIES, IMPACT, AND CAUSES, 2023-2024
  • TABLE 5 HEALTHCARE ANALYTICS MARKET: ROLE OF COMPANIES IN ECOSYSTEM
  • TABLE 6 NORTH AMERICA: REGULATIONS GOVERNING HEALTHCARE ANALYTICS MARKET
  • TABLE 7 EUROPE: REGULATIONS GOVERNING HEALTHCARE ANALYTICS MARKET
  • TABLE 8 ASIA PACIFIC: REGULATIONS GOVERNING HEALTHCARE ANALYTICS MARKET
  • TABLE 9 MIDDLE EAST & AFRICA: REGULATIONS GOVERNING HEALTHCARE ANALYTICS MARKET
  • TABLE 10 LATIN AMERICA: REGULATIONS GOVERNING HEALTHCARE ANALYTICS MARKET
  • TABLE 11 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 12 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 13 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 14 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 15 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 16 AVERAGE SELLING PRICE OF HEALTHCARE ANALYTICS SOLUTIONS, BY COMPONENT
  • TABLE 17 AVERAGE SELLING PRICE OF ANALYTICS SOLUTIONS, BY REGION
  • TABLE 18 HEALTHCARE ANALYTICS MARKET: PORTER'S FIVE FORCES ANALYSIS
  • TABLE 19 HEALTHCARE ANALYTICS MARKET: INNOVATIONS AND PATENT REGISTRATIONS, 2021-2024
  • TABLE 20 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP THREE END USERS (%)
  • TABLE 21 KEY BUYING CRITERIA FOR END USERS
  • TABLE 22 UNMET NEEDS IN HEALTHCARE ANALYTICS MARKET
  • TABLE 23 END-USER EXPECTATIONS IN HEALTHCARE ANALYTICS MARKET
  • TABLE 24 HEALTHCARE ANALYTICS MARKET: KEY CONFERENCES AND EVENTS, 2024-2025
  • TABLE 25 ADOPTION OF HEALTH CATALYST DATA OPERATING SYSTEM FOR IMPROVED ANNUAL SAVINGS
  • TABLE 26 USE OF COMPREHENSIVE DATA ANALYTICS PLATFORM TO MEET NEEDS OF EVOLVING HEALTHCARE ENVIRONMENT
  • TABLE 27 ENHANCED CLINICAL DECISION-MAKING PROCESS WITH DATA OPERATING SYSTEM PLATFORM
  • TABLE 28 ENHANCED PATIENT OUTCOMES WITH AI-DRIVEN PREDICTIVE ANALYTICS
  • TABLE 29 HEALTHCARE ANALYTICS MARKET, BY COMPONENT, 2022-2029 (USD MILLION)
  • TABLE 30 HEALTHCARE ANALYTICS SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 31 HEALTHCARE ANALYTICS SERVICES MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 32 HEALTHCARE ANALYTICS MARKET FOR MANAGED SERVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 33 HEALTHCARE ANALYTICS MARKET FOR MANAGED SERVICES, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 34 HEALTHCARE ANALYTICS MARKET FOR ANALYTICAL SERVICES, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 35 HEALTHCARE ANALYTICS MARKET FOR CONSULTING SERVICES, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 36 HEALTHCARE ANALYTICS MARKET FOR PROFESSIONAL SERVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 37 HEALTHCARE ANALYTICS MARKET FOR PROFESSIONAL SERVICES, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 38 HEALTHCARE ANALYTICS MARKET FOR TRAINING & IMPLEMENTATION SERVICES, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 39 HEALTHCARE ANALYTICS MARKET FOR MAINTENANCE & SUPPORT SERVICES, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 40 HEALTHCARE ANALYTICS SOFTWARE MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 41 HEALTHCARE ANALYTICS SOFTWARE MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 42 HEALTHCARE ANALYTICS MARKET FOR ON-PREMISE SOFTWARE, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 43 HEALTHCARE ANALYTICS MARKET FOR CLOUD-BASED SOFTWARE, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 44 HEALTHCARE ANALYTICS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 45 DESCRIPTIVE ANALYTICS MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 46 APPLICATIONS OF PREDICTIVE ANALYTICS
  • TABLE 47 COMMERCIALLY AVAILABLE PREDICTIVE ANALYTICS SOLUTIONS
  • TABLE 48 PREDICTIVE ANALYTICS MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 49 COMMERCIALLY AVAILABLE PRESCRIPTIVE ANALYTICS SOLUTIONS
  • TABLE 50 PRESCRIPTIVE ANALYTICS MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 51 DIAGNOSTIC ANALYTICS MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 52 HEALTHCARE ANALYTICS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 53 COMMERCIALLY AVAILABLE FINANCIAL ANALYTICS SOLUTIONS
  • TABLE 54 FINANCIAL ANALYTICS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 55 FINANCIAL ANALYTICS MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 56 COMMERCIALLY AVAILABLE CLAIMS PROCESSING SOLUTIONS
  • TABLE 57 FINANCIAL ANALYTICS MARKET FOR CLAIMS PROCESSING, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 58 COMMERCIALLY AVAILABLE REVENUE CYCLE MANAGEMENT SOLUTIONS
  • TABLE 59 FINANCIAL ANALYTICS MARKET FOR REVENUE CYCLE MANAGEMENT, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 60 COMMERCIALLY AVAILABLE PAYMENT INTEGRITY & FWA SOLUTIONS
  • TABLE 61 FINANCIAL ANALYTICS MARKET FOR PAYMENT INTEGRITY & FWA, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 62 COMMERCIALLY AVAILABLE RISK ADJUSTMENT & ASSESSMENT SOLUTIONS
  • TABLE 63 FINANCIAL ANALYTICS MARKET FOR RISK ADJUSTMENT & ASSESSMENT, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 64 COMMERCIALLY AVAILABLE CLINICAL ANALYTICS SOLUTIONS
  • TABLE 65 CLINICAL ANALYTICS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 66 CLINICAL ANALYTICS MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 67 COMMERCIALLY AVAILABLE QUALITY IMPROVEMENT & CLINICAL BENCHMARKING SOLUTIONS
  • TABLE 68 CLINICAL ANALYTICS MARKET FOR QUALITY IMPROVEMENT & CLINICAL BENCHMARKING, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 69 COMMERCIALLY AVAILABLE SOLUTIONS FOR CLINICAL DECISION SUPPORT
  • TABLE 70 CLINICAL ANALYTICS MARKET FOR CLINICAL DECISION SUPPORT, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 71 COMMERCIALLY AVAILABLE SOLUTIONS FOR REPORTING & COMPLIANCE
  • TABLE 72 CLINICAL ANALYTICS MARKET FOR REPORTING & COMPLIANCE, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 73 COMMERCIALLY AVAILABLE SOLUTIONS FOR COMPARATIVE ANALYTICS/EFFECTIVENESS
  • TABLE 74 CLINICAL ANALYTICS MARKET FOR COMPARATIVE ANALYTICS/EFFECTIVENESS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 75 COMMERCIALLY AVAILABLE PRECISION HEALTH/REAL-WORLD EVIDENCE SOLUTIONS
  • TABLE 76 CLINICAL ANALYTICS MARKET FOR PRECISION HEALTH/REAL-WORLD EVIDENCE, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 77 COMMERCIALLY AVAILABLE SOLUTIONS FOR MEDICAL IMAGING ANALYTICS
  • TABLE 78 CLINICAL ANALYTICS MARKET FOR MEDICAL IMAGING ANALYTICS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 79 COMMERCIALLY AVAILABLE SOLUTIONS FOR OPERATIONAL & ADMINISTRATIVE ANALYTICS
  • TABLE 80 OPERATIONAL & ADMINISTRATIVE ANALYTICS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 81 OPERATIONAL & ADMINISTRATIVE ANALYTICS MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 82 COMMERCIALLY AVAILABLE SUPPLY CHAIN ANALYTICS SOLUTIONS
  • TABLE 83 OPERATIONAL & ADMINISTRATIVE ANALYTICS MARKET FOR SUPPLY CHAIN ANALYTICS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 84 COMMERCIALLY AVAILABLE WORKFORCE ANALYTICS SOLUTIONS
  • TABLE 85 OPERATIONAL & ADMINISTRATIVE ANALYTICS MARKET FOR WORKFORCE ANALYTICS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 86 OPERATIONAL & ADMINISTRATIVE ANALYTICS MARKET FOR STRATEGIC ANALYTICS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 87 COMMERCIALLY AVAILABLE POPULATION HEALTH ANALYTICS SOLUTIONS
  • TABLE 88 POPULATION HEALTH ANALYTICS MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 89 HEALTHCARE ANALYTICS MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 90 COMMERCIALLY AVAILABLE SOLUTIONS FOR HEALTHCARE PAYERS
  • TABLE 91 HEALTHCARE ANALYTICS MARKET FOR PAYERS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 92 HEALTHCARE ANALYTICS MARKET FOR PAYERS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 93 HEALTHCARE ANALYTICS MARKET FOR PRIVATE INSURANCE COMPANIES, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 94 HEALTHCARE ANALYTICS MARKET FOR GOVERNMENT AGENCIES, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 95 COMMERCIALLY AVAILABLE ANALYTICS SOLUTIONS FOR HEALTHCARE PROVIDERS
  • TABLE 96 HEALTHCARE ANALYTICS MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 97 HEALTHCARE ANALYTICS MARKET FOR HEALTHCARE PROVIDERS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 98 COMMERCIALLY AVAILABLE HEALTHCARE ANALYTICS SOLUTIONS FOR HOSPITALS & CLINICS
  • TABLE 99 HEALTHCARE ANALYTICS MARKET FOR HOSPITALS & CLINICS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 100 HEALTHCARE ANALYTICS MARKET FOR POST-ACUTE CARE ORGANIZATIONS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 101 COMMERCIALLY AVAILABLE HEALTHCARE ANALYTICS SOLUTIONS FOR AMBULATORY SURGERY CENTERS
  • TABLE 102 HEALTHCARE ANALYTICS MARKET FOR AMBULATORY SURGERY CENTERS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 103 COMMERCIALLY AVAILABLE SOLUTIONS FOR ACCOUNTABLE CARE ORGANIZATIONS
  • TABLE 104 HEALTHCARE ANALYTICS MARKET FOR OTHER PROVIDERS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 105 HEALTHCARE ANALYTICS MARKET FOR PHARMACEUTICAL & MEDICAL DEVICE SUPPLY CHAIN, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 106 HEALTHCARE ANALYTICS MARKET FOR PHARMACEUTICAL & MEDICAL DEVICE SUPPLY CHAIN, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 107 HEALTHCARE ANALYTICS MARKET FOR MANUFACTURERS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 108 HEALTHCARE ANALYTICS MARKET FOR DISTRIBUTORS & WHOLESALERS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 109 HEALTHCARE ANALYTICS MARKET FOR RETAILERS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 110 HEALTHCARE ANALYTICS MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 111 NORTH AMERICA: HEALTHCARE ANALYTICS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 112 NORTH AMERICA: HEALTHCARE ANALYTICS MARKET, BY COMPONENT, 2022-2029 (USD MILLION)
  • TABLE 113 NORTH AMERICA: HEALTHCARE ANALYTICS SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 114 NORTH AMERICA: HEALTHCARE ANALYTICS MARKET FOR MANAGED SERVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 115 NORTH AMERICA: HEALTHCARE ANALYTICS MARKET FOR PROFESSIONAL SERVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 116 NORTH AMERICA: HEALTHCARE ANALYTICS SOFTWARE MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 117 NORTH AMERICA: HEALTHCARE ANALYTICS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 118 NORTH AMERICA: HEALTHCARE ANALYTICS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 119 NORTH AMERICA: FINANCIAL ANALYTICS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 120 NORTH AMERICA: CLINICAL ANALYTICS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 121 NORTH AMERICA: OPERATIONAL & ADMINISTRATIVE ANALYTICS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 122 NORTH AMERICA: HEALTHCARE ANALYTICS MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 123 NORTH AMERICA: HEALTHCARE ANALYTICS MARKET FOR PAYERS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 124 NORTH AMERICA: HEALTHCARE ANALYTICS MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 125 NORTH AMERICA: HEALTHCARE ANALYTICS MARKET FOR PHARMACEUTICAL & MEDICAL DEVICE SUPPLY CHAIN, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 126 US: HEALTHCARE ANALYTICS MARKET, BY COMPONENT, 2022-2029 (USD MILLION)
  • TABLE 127 US: HEALTHCARE ANALYTICS SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 128 US: HEALTHCARE ANALYTICS MARKET FOR MANAGED SERVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 129 US: HEALTHCARE ANALYTICS MARKET FOR PROFESSIONAL SERVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 130 US: HEALTHCARE ANALYTICS SOFTWARE MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 131 US: HEALTHCARE ANALYTICS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 132 US: HEALTHCARE ANALYTICS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 133 US: FINANCIAL ANALYTICS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 134 US: CLINICAL ANALYTICS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 135 US: OPERATIONAL & ADMINISTRATIVE ANALYTICS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 136 US: HEALTHCARE ANALYTICS MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 137 US: HEALTHCARE ANALYTICS MARKET FOR PAYERS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 138 US: HEALTHCARE ANALYTICS MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 139 US: HEALTHCARE ANALYTICS MARKET FOR PHARMACEUTICAL & MEDICAL DEVICE SUPPLY CHAIN, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 140 CANADA: HEALTHCARE ANALYTICS MARKET, BY COMPONENT, 2022-2029 (USD MILLION)
  • TABLE 141 CANADA: HEALTHCARE ANALYTICS SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 142 CANADA: HEALTHCARE ANALYTICS MARKET FOR MANAGED SERVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 143 CANADA: HEALTHCARE ANALYTICS MARKET FOR PROFESSIONAL SERVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 144 CANADA: HEALTHCARE ANALYTICS SOFTWARE MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 145 CANADA: HEALTHCARE ANALYTICS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 146 CANADA: HEALTHCARE ANALYTICS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 147 CANADA: FINANCIAL ANALYTICS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 148 CANADA: CLINICAL ANALYTICS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 149 CANADA: OPERATIONAL & ADMINISTRATIVE ANALYTICS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 150 CANADA: HEALTHCARE ANALYTICS MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 151 CANADA: HEALTHCARE ANALYTICS MARKET FOR PAYERS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 152 CANADA: HEALTHCARE ANALYTICS MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 153 CANADA: HEALTHCARE ANALYTICS MARKET FOR PHARMACEUTICAL & MEDICAL DEVICE SUPPLY CHAIN, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 154 EUROPE: HEALTHCARE ANALYTICS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 155 EUROPE: HEALTHCARE ANALYTICS MARKET, BY COMPONENT, 2022-2029 (USD MILLION)
  • TABLE 156 EUROPE: HEALTHCARE ANALYTICS SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 157 EUROPE: HEALTHCARE ANALYTICS MARKET FOR MANAGED SERVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 158 EUROPE: HEALTHCARE ANALYTICS MARKET FOR PROFESSIONAL SERVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 159 EUROPE: HEALTHCARE ANALYTICS SOFTWARE MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 160 EUROPE: HEALTHCARE ANALYTICS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 161 EUROPE: HEALTHCARE ANALYTICS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 162 EUROPE: FINANCIAL ANALYTICS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 163 EUROPE: CLINICAL ANALYTICS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 164 EUROPE: OPERATIONAL & ADMINISTRATIVE ANALYTICS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 165 EUROPE: HEALTHCARE ANALYTICS MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 166 EUROPE: HEALTHCARE ANALYTICS MARKET FOR PAYERS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 167 EUROPE: HEALTHCARE ANALYTICS MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 168 EUROPE: HEALTHCARE ANALYTICS MARKET FOR PHARMACEUTICAL & MEDICAL DEVICE SUPPLY CHAIN, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 169 GERMANY: HEALTHCARE ANALYTICS MARKET, BY COMPONENT, 2022-2029 (USD MILLION)
  • TABLE 170 GERMANY: HEALTHCARE ANALYTICS SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 171 GERMANY: HEALTHCARE ANALYTICS MARKET FOR MANAGED SERVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 172 GERMANY: HEALTHCARE ANALYTICS MARKET FOR PROFESSIONAL SERVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 173 GERMANY: HEALTHCARE ANALYTICS SOFTWARE MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 174 GERMANY: HEALTHCARE ANALYTICS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 175 GERMANY: HEALTHCARE ANALYTICS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 176 GERMANY: FINANCIAL ANALYTICS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 177 GERMANY: CLINICAL ANALYTICS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 178 GERMANY: OPERATIONAL & ADMINISTRATIVE ANALYTICS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 179 GERMANY: HEALTHCARE ANALYTICS MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 180 GERMANY: HEALTHCARE ANALYTICS MARKET FOR PAYERS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 181 GERMANY: HEALTHCARE ANALYTICS MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 182 GERMANY: HEALTHCARE ANALYTICS MARKET FOR PHARMACEUTICAL & MEDICAL DEVICE SUPPLY CHAIN, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 183 UK: HEALTHCARE ANALYTICS MARKET, BY COMPONENT, 2022-2029 (USD MILLION)
  • TABLE 184 UK: HEALTHCARE ANALYTICS SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 185 UK: HEALTHCARE ANALYTICS MARKET FOR MANAGED SERVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 186 UK: HEALTHCARE ANALYTICS MARKET FOR PROFESSIONAL SERVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 187 UK: HEALTHCARE ANALYTICS SOFTWARE MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 188 UK: HEALTHCARE ANALYTICS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 189 UK: HEALTHCARE ANALYTICS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 190 UK: FINANCIAL ANALYTICS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 191 UK: CLINICAL ANALYTICS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 192 UK: OPERATIONAL & ADMINISTRATIVE ANALYTICS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 193 UK: HEALTHCARE ANALYTICS MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 194 UK: HEALTHCARE ANALYTICS MARKET FOR PAYERS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 195 UK: HEALTHCARE ANALYTICS MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 196 UK: HEALTHCARE ANALYTICS MARKET FOR PHARMACEUTICAL & MEDICAL DEVICE SUPPLY CHAIN, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 197 FRANCE: HEALTHCARE ANALYTICS MARKET, BY COMPONENT, 2022-2029 (USD MILLION)
  • TABLE 198 FRANCE: HEALTHCARE ANALYTICS SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 199 FRANCE: HEALTHCARE ANALYTICS MARKET FOR MANAGED SERVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 200 FRANCE: HEALTHCARE ANALYTICS MARKET FOR PROFESSIONAL SERVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 201 FRANCE: HEALTHCARE ANALYTICS SOFTWARE MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 202 FRANCE: HEALTHCARE ANALYTICS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 203 FRANCE: HEALTHCARE ANALYTICS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 204 FRANCE: FINANCIAL ANALYTICS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 205 FRANCE: CLINICAL ANALYTICS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 206 FRANCE: OPERATIONAL & ADMINISTRATIVE ANALYTICS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 207 FRANCE: HEALTHCARE ANALYTICS MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 208 FRANCE: HEALTHCARE ANALYTICS MARKET FOR PAYERS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 209 FRANCE: HEALTHCARE ANALYTICS MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 210 FRANCE: HEALTHCARE ANALYTICS MARKET FOR PHARMACEUTICAL & MEDICAL DEVICE SUPPLY CHAIN, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 211 ITALY: HEALTHCARE ANALYTICS MARKET, BY COMPONENT, 2022-2029 (USD MILLION)
  • TABLE 212 ITALY: HEALTHCARE ANALYTICS SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 213 ITALY: HEALTHCARE ANALYTICS MARKET FOR MANAGED SERVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 214 ITALY: HEALTHCARE ANALYTICS MARKET FOR PROFESSIONAL SERVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 215 ITALY: HEALTHCARE ANALYTICS SOFTWARE MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 216 ITALY: HEALTHCARE ANALYTICS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 217 ITALY: HEALTHCARE ANALYTICS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 218 ITALY: FINANCIAL ANALYTICS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 219 ITALY: CLINICAL ANALYTICS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 220 ITALY: OPERATIONAL & ADMINISTRATIVE ANALYTICS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 221 ITALY: HEALTHCARE ANALYTICS MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 222 ITALY: HEALTHCARE ANALYTICS MARKET FOR PAYERS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 223 ITALY: HEALTHCARE ANALYTICS MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 224 ITALY: HEALTHCARE ANALYTICS MARKET FOR PHARMACEUTICAL & MEDICAL DEVICE SUPPLY CHAIN, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 225 SPAIN: HEALTHCARE ANALYTICS MARKET, BY COMPONENT, 2022-2029 (USD MILLION)
  • TABLE 226 SPAIN: HEALTHCARE ANALYTICS SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 227 SPAIN: HEALTHCARE ANALYTICS MARKET FOR MANAGED SERVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 228 SPAIN: HEALTHCARE ANALYTICS MARKET FOR PROFESSIONAL SERVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 229 SPAIN: HEALTHCARE ANALYTICS SOFTWARE MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 230 SPAIN: HEALTHCARE ANALYTICS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 231 SPAIN: HEALTHCARE ANALYTICS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 232 SPAIN: FINANCIAL ANALYTICS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 233 SPAIN: CLINICAL ANALYTICS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 234 SPAIN: OPERATIONAL & ADMINISTRATIVE ANALYTICS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 235 SPAIN: HEALTHCARE ANALYTICS MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 236 SPAIN: HEALTHCARE ANALYTICS MARKET FOR PAYERS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 237 SPAIN: HEALTHCARE ANALYTICS MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 238 SPAIN: HEALTHCARE ANALYTICS MARKET FOR PHARMACEUTICAL & MEDICAL DEVICE SUPPLY CHAIN, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 239 REST OF EUROPE: HEALTHCARE ANALYTICS MARKET, BY COMPONENT, 2022-2029 (USD MILLION)
  • TABLE 240 REST OF EUROPE: HEALTHCARE ANALYTICS SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 241 REST OF EUROPE: HEALTHCARE ANALYTICS MARKET FOR MANAGED SERVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 242 REST OF EUROPE: HEALTHCARE ANALYTICS MARKET FOR PROFESSIONAL SERVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 243 REST OF EUROPE: HEALTHCARE ANALYTICS SOFTWARE MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 244 REST OF EUROPE: HEALTHCARE ANALYTICS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 245 REST OF EUROPE: HEALTHCARE ANALYTICS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 246 REST OF EUROPE: FINANCIAL ANALYTICS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 247 REST OF EUROPE: CLINICAL ANALYTICS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 248 REST OF EUROPE: OPERATIONAL & ADMINISTRATIVE ANALYTICS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 249 REST OF EUROPE: HEALTHCARE ANALYTICS MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 250 REST OF EUROPE: HEALTHCARE ANALYTICS MARKET FOR PAYERS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 251 REST OF EUROPE: HEALTHCARE ANALYTICS MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 252 REST OF EUROPE: HEALTHCARE ANALYTICS MARKET FOR PHARMACEUTICAL & MEDICAL DEVICE SUPPLY CHAIN, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 253 ASIA PACIFIC: HEALTHCARE ANALYTICS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 254 ASIA PACIFIC: HEALTHCARE ANALYTICS MARKET, BY COMPONENT, 2022-2029 (USD MILLION)
  • TABLE 255 ASIA PACIFIC: HEALTHCARE ANALYTICS SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 256 ASIA PACIFIC: HEALTHCARE ANALYTICS MARKET FOR MANAGED SERVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 257 ASIA PACIFIC: HEALTHCARE ANALYTICS MARKET FOR PROFESSIONAL SERVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 258 ASIA PACIFIC: HEALTHCARE ANALYTICS SOFTWARE MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 259 ASIA PACIFIC: HEALTHCARE ANALYTICS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 260 ASIA PACIFIC: HEALTHCARE ANALYTICS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 261 ASIA PACIFIC: FINANCIAL ANALYTICS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 262 ASIA PACIFIC: CLINICAL ANALYTICS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 263 ASIA PACIFIC: OPERATIONAL & ADMINISTRATIVE ANALYTICS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 264 ASIA PACIFIC: HEALTHCARE ANALYTICS MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 265 ASIA PACIFIC: HEALTHCARE ANALYTICS MARKET FOR PAYERS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 266 ASIA PACIFIC: HEALTHCARE ANALYTICS MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 267 ASIA PACIFIC: HEALTHCARE ANALYTICS MARKET FOR PHARMACEUTICAL & MEDICAL DEVICE SUPPLY CHAIN, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 268 JAPAN: HEALTHCARE ANALYTICS MARKET, BY COMPONENT, 2022-2029 (USD MILLION)
  • TABLE 269 JAPAN: HEALTHCARE ANALYTICS SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 270 JAPAN: HEALTHCARE ANALYTICS MARKET FOR MANAGED SERVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 271 JAPAN: HEALTHCARE ANALYTICS MARKET FOR PROFESSIONAL SERVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 272 JAPAN: HEALTHCARE ANALYTICS SOFTWARE MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 273 JAPAN: HEALTHCARE ANALYTICS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 274 JAPAN: HEALTHCARE ANALYTICS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 275 JAPAN: FINANCIAL ANALYTICS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 276 JAPAN: CLINICAL ANALYTICS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 277 JAPAN: OPERATIONAL & ADMINISTRATIVE ANALYTICS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 278 JAPAN: HEALTHCARE ANALYTICS MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 279 JAPAN: HEALTHCARE ANALYTICS MARKET FOR PAYERS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 280 JAPAN: HEALTHCARE ANALYTICS MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 281 JAPAN: HEALTHCARE ANALYTICS MARKET FOR PHARMACEUTICAL & MEDICAL DEVICE SUPPLY CHAIN, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 282 CHINA: HEALTHCARE ANALYTICS MARKET, BY COMPONENT, 2022-2029 (USD MILLION)
  • TABLE 283 CHINA: HEALTHCARE ANALYTICS SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 284 CHINA: HEALTHCARE ANALYTICS MARKET FOR MANAGED SERVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 285 CHINA: HEALTHCARE ANALYTICS MARKET FOR PROFESSIONAL SERVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 286 CHINA: HEALTHCARE ANALYTICS SOFTWARE MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 287 CHINA: HEALTHCARE ANALYTICS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 288 CHINA: HEALTHCARE ANALYTICS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 289 CHINA: FINANCIAL ANALYTICS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 290 CHINA: CLINICAL ANALYTICS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 291 CHINA: OPERATIONAL & ADMINISTRATIVE ANALYTICS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 292 CHINA: HEALTHCARE ANALYTICS MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 293 CHINA: HEALTHCARE ANALYTICS MARKET FOR PAYERS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 294 CHINA: HEALTHCARE ANALYTICS MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 295 CHINA: HEALTHCARE ANALYTICS MARKET FOR PHARMACEUTICAL & MEDICAL DEVICE SUPPLY CHAIN, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 296 INDIA: HEALTHCARE ANALYTICS MARKET, BY COMPONENT, 2022-2029 (USD MILLION)
  • TABLE 297 INDIA: HEALTHCARE ANALYTICS SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 298 INDIA: HEALTHCARE ANALYTICS MARKET FOR MANAGED SERVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 299 INDIA: HEALTHCARE ANALYTICS MARKET FOR PROFESSIONAL SERVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 300 INDIA: HEALTHCARE ANALYTICS SOFTWARE MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 301 INDIA: HEALTHCARE ANALYTICS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 302 INDIA: HEALTHCARE ANALYTICS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 303 INDIA: FINANCIAL ANALYTICS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 304 INDIA: CLINICAL ANALYTICS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 305 INDIA: OPERATIONAL & ADMINISTRATIVE ANALYTICS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 306 INDIA: HEALTHCARE ANALYTICS MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 307 INDIA: HEALTHCARE ANALYTICS MARKET FOR PAYERS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 308 INDIA: HEALTHCARE ANALYTICS MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 309 INDIA: HEALTHCARE ANALYTICS MARKET FOR PHARMACEUTICAL & MEDICAL DEVICE SUPPLY CHAIN, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 310 REST OF ASIA PACIFIC: HEALTHCARE ANALYTICS MARKET, BY COMPONENT, 2022-2029 (USD MILLION)
  • TABLE 311 REST OF ASIA PACIFIC: HEALTHCARE ANALYTICS SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 312 REST OF ASIA PACIFIC: HEALTHCARE ANALYTICS MARKET FOR MANAGED SERVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 313 REST OF ASIA PACIFIC: HEALTHCARE ANALYTICS MARKET FOR PROFESSIONAL SERVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 314 REST OF ASIA PACIFIC: HEALTHCARE ANALYTICS SOFTWARE MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 315 REST OF ASIA PACIFIC: HEALTHCARE ANALYTICS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 316 REST OF ASIA PACIFIC: HEALTHCARE ANALYTICS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 317 REST OF ASIA PACIFIC: FINANCIAL ANALYTICS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 318 REST OF ASIA PACIFIC: CLINICAL ANALYTICS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 319 REST OF ASIA PACIFIC: OPERATIONAL & ADMINISTRATIVE ANALYTICS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 320 REST OF ASIA PACIFIC: HEALTHCARE ANALYTICS MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 321 REST OF ASIA PACIFIC: HEALTHCARE ANALYTICS MARKET FOR PAYERS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 322 REST OF ASIA PACIFIC: HEALTHCARE ANALYTICS MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 323 REST OF ASIA PACIFIC: HEALTHCARE ANALYTICS MARKET FOR PHARMACEUTICAL & MEDICAL DEVICE SUPPLY CHAIN, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 324 LATIN AMERICA: HEALTHCARE ANALYTICS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 325 LATIN AMERICA: HEALTHCARE ANALYTICS MARKET, BY COMPONENT, 2022-2029 (USD MILLION)
  • TABLE 326 LATIN AMERICA: HEALTHCARE ANALYTICS SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 327 LATIN AMERICA: HEALTHCARE ANALYTICS MARKET FOR MANAGED SERVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 328 LATIN AMERICA: HEALTHCARE ANALYTICS MARKET FOR PROFESSIONAL SERVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 329 LATIN AMERICA: HEALTHCARE ANALYTICS SOFTWARE MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 330 LATIN AMERICA: HEALTHCARE ANALYTICS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 331 LATIN AMERICA: HEALTHCARE ANALYTICS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 332 LATIN AMERICA: FINANCIAL ANALYTICS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 333 LATIN AMERICA: CLINICAL ANALYTICS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 334 LATIN AMERICA: OPERATIONAL & ADMINISTRATIVE ANALYTICS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 335 LATIN AMERICA: HEALTHCARE ANALYTICS MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 336 LATIN AMERICA: HEALTHCARE ANALYTICS MARKET FOR PAYERS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 337 LATIN AMERICA: HEALTHCARE ANALYTICS MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 338 LATIN AMERICA: HEALTHCARE ANALYTICS MARKET FOR PHARMACEUTICAL & MEDICAL DEVICE SUPPLY CHAIN, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 339 BRAZIL: HEALTHCARE ANALYTICS MARKET, BY COMPONENT, 2022-2029 (USD MILLION)
  • TABLE 340 BRAZIL: HEALTHCARE ANALYTICS SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 341 BRAZIL: HEALTHCARE ANALYTICS MARKET FOR MANAGED SERVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 342 BRAZIL: HEALTHCARE ANALYTICS MARKET FOR PROFESSIONAL SERVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 343 BRAZIL: HEALTHCARE ANALYTICS SOFTWARE MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 344 BRAZIL: HEALTHCARE ANALYTICS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 345 BRAZIL: HEALTHCARE ANALYTICS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 346 BRAZIL: FINANCIAL ANALYTICS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 347 BRAZIL: CLINICAL ANALYTICS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 348 BRAZIL: OPERATIONAL & ADMINISTRATIVE ANALYTICS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 349 BRAZIL: HEALTHCARE ANALYTICS MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 350 BRAZIL: HEALTHCARE ANALYTICS MARKET FOR PAYERS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 351 BRAZIL: HEALTHCARE ANALYTICS MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 352 BRAZIL: HEALTHCARE ANALYTICS MARKET FOR PHARMACEUTICAL & MEDICAL DEVICE SUPPLY CHAIN, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 353 MEXICO: HEALTHCARE ANALYTICS MARKET, BY COMPONENT, 2022-2029 (USD MILLION)
  • TABLE 354 MEXICO: HEALTHCARE ANALYTICS SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 355 MEXICO: HEALTHCARE ANALYTICS MARKET FOR MANAGED SERVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 356 MEXICO: HEALTHCARE ANALYTICS MARKET FOR PROFESSIONAL SERVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 357 MEXICO: HEALTHCARE ANALYTICS SOFTWARE MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 358 MEXICO: HEALTHCARE ANALYTICS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 359 MEXICO: HEALTHCARE ANALYTICS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 360 MEXICO: FINANCIAL ANALYTICS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 361 MEXICO: CLINICAL ANALYTICS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 362 MEXICO: OPERATIONAL & ADMINISTRATIVE ANALYTICS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 363 MEXICO: HEALTHCARE ANALYTICS MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 364 MEXICO: HEALTHCARE ANALYTICS MARKET FOR PAYERS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 365 MEXICO: HEALTHCARE ANALYTICS MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 366 MEXICO: HEALTHCARE ANALYTICS MARKET FOR PHARMACEUTICAL & MEDICAL DEVICE SUPPLY CHAIN, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 367 REST OF LATIN AMERICA: HEALTHCARE ANALYTICS MARKET, BY COMPONENT, 2022-2029 (USD MILLION)
  • TABLE 368 REST OF LATIN AMERICA: HEALTHCARE ANALYTICS SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 369 REST OF LATIN AMERICA: HEALTHCARE ANALYTICS MARKET FOR MANAGED SERVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 370 REST OF LATIN AMERICA: HEALTHCARE ANALYTICS MARKET FOR PROFESSIONAL SERVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 371 REST OF LATIN AMERICA: HEALTHCARE ANALYTICS SOFTWARE MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 372 REST OF LATIN AMERICA: HEALTHCARE ANALYTICS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 373 REST OF LATIN AMERICA: HEALTHCARE ANALYTICS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 374 REST OF LATIN AMERICA: FINANCIAL ANALYTICS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 375 REST OF LATIN AMERICA: CLINICAL ANALYTICS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 376 REST OF LATIN AMERICA: OPERATIONAL & ADMINISTRATIVE ANALYTICS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 377 REST OF LATIN AMERICA: HEALTHCARE ANALYTICS MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 378 REST OF LATIN AMERICA: HEALTHCARE ANALYTICS MARKET FOR PAYERS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 379 REST OF LATIN AMERICA: HEALTHCARE ANALYTICS MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 380 REST OF LATIN AMERICA: HEALTHCARE ANALYTICS MARKET FOR PHARMACEUTICAL & MEDICAL DEVICE SUPPLY CHAIN, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 381 MIDDLE EAST & AFRICA: HEALTHCARE ANALYTICS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 382 MIDDLE EAST & AFRICA: HEALTHCARE ANALYTICS MARKET, BY COMPONENT, 2022-2029 (USD MILLION)
  • TABLE 383 MIDDLE EAST & AFRICA: HEALTHCARE ANALYTICS SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 384 MIDDLE EAST & AFRICA: HEALTHCARE ANALYTICS MARKET FOR MANAGED SERVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 385 MIDDLE EAST & AFRICA: HEALTHCARE ANALYTICS MARKET FOR PROFESSIONAL SERVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 386 MIDDLE EAST & AFRICA: HEALTHCARE ANALYTICS SOFTWARE MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 387 MIDDLE EAST & AFRICA: HEALTHCARE ANALYTICS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 388 MIDDLE EAST & AFRICA: HEALTHCARE ANALYTICS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 389 MIDDLE EAST & AFRICA: FINANCIAL ANALYTICS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 390 MIDDLE EAST & AFRICA: CLINICAL ANALYTICS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 391 MIDDLE EAST & AFRICA: OPERATIONAL & ADMINISTRATIVE ANALYTICS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 392 MIDDLE EAST & AFRICA: HEALTHCARE ANALYTICS MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 393 MIDDLE EAST & AFRICA: HEALTHCARE ANALYTICS MARKET FOR PAYERS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 394 MIDDLE EAST & AFRICA: HEALTHCARE ANALYTICS MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 395 MIDDLE EAST & AFRICA: HEALTHCARE ANALYTICS MARKET FOR PHARMACEUTICAL & MEDICAL DEVICE SUPPLY CHAIN, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 396 GCC COUNTRIES: HEALTHCARE ANALYTICS MARKET, BY COMPONENT, 2022-2029 (USD MILLION)
  • TABLE 397 GCC COUNTRIES: HEALTHCARE ANALYTICS SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 398 GCC COUNTRIES: HEALTHCARE ANALYTICS MARKET FOR MANAGED SERVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 399 GCC COUNTRIES: HEALTHCARE ANALYTICS MARKET FOR PROFESSIONAL SERVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 400 GCC COUNTRIES: HEALTHCARE ANALYTICS SOFTWARE MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 401 GCC COUNTRIES: HEALTHCARE ANALYTICS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 402 GCC COUNTRIES: HEALTHCARE ANALYTICS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 403 GCC COUNTRIES: FINANCIAL ANALYTICS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 404 GCC COUNTRIES: CLINICAL ANALYTICS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 405 GCC COUNTRIES: OPERATIONAL & ADMINISTRATIVE ANALYTICS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 406 GCC COUNTRIES: HEALTHCARE ANALYTICS MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 407 GCC COUNTRIES: HEALTHCARE ANALYTICS MARKET FOR PAYERS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 408 GCC COUNTRIES: HEALTHCARE ANALYTICS MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 409 GCC COUNTRIES: HEALTHCARE ANALYTICS MARKET FOR PHARMACEUTICAL & MEDICAL DEVICE SUPPLY CHAIN, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 410 REST OF MIDDLE EAST & AFRICA: HEALTHCARE ANALYTICS MARKET, BY COMPONENT, 2022-2029 (USD MILLION)
  • TABLE 411 REST OF MIDDLE EAST & AFRICA: HEALTHCARE ANALYTICS SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 412 REST OF MIDDLE EAST & AFRICA: HEALTHCARE ANALYTICS MARKET FOR MANAGED SERVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 413 REST OF MIDDLE EAST & AFRICA: HEALTHCARE ANALYTICS MARKET FOR PROFESSIONAL SERVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 414 REST OF MIDDLE EAST & AFRICA: HEALTHCARE ANALYTICS SOFTWARE MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 415 REST OF MIDDLE EAST & AFRICA: HEALTHCARE ANALYTICS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 416 REST OF MIDDLE EAST & AFRICA: HEALTHCARE ANALYTICS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 417 REST OF MIDDLE EAST & AFRICA: FINANCIAL ANALYTICS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 418 REST OF MIDDLE EAST & AFRICA: CLINICAL ANALYTICS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 419 REST OF MIDDLE EAST & AFRICA: OPERATIONAL & ADMINISTRATIVE ANALYTICS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 420 REST OF MIDDLE EAST & AFRICA: HEALTHCARE ANALYTICS MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 421 REST OF MIDDLE EAST & AFRICA HEALTHCARE ANALYTICS MARKET FOR PAYERS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 422 REST OF MIDDLE EAST & AFRICA: HEALTHCARE ANALYTICS MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 423 REST OF MIDDLE EAST & AFRICA: HEALTHCARE ANALYTICS MARKET FOR PHARMACEUTICAL & MEDICAL DEVICE SUPPLY CHAIN, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 424 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN HEALTHCARE ANALYTICS MARKET, 2021-2025
  • TABLE 425 HEALTHCARE ANALYTICS MARKET: DEGREE OF COMPETITION
  • TABLE 426 HEALTHCARE ANALYTICS MARKET: REGION FOOTPRINT
  • TABLE 427 HEALTHCARE ANALYTICS MARKET: COMPONENT FOOTPRINT
  • TABLE 428 HEALTHCARE ANALYTICS MARKET: APPLICATION FOOTPRINT
  • TABLE 429 HEALTHCARE ANALYTICS MARKET: END-USER FOOTPRINT
  • TABLE 430 HEALTHCARE ANALYTICS MARKET: KEY STARTUPS/SMES
  • TABLE 431 HEALTHCARE ANALYTICS MARKET: COMPETITIVE BENCHMARKING OF STARTUPS/SMES
  • TABLE 432 HEALTHCARE ANALYTICS MARKET: PRODUCT/SOLUTION LAUNCHES/ENHANCEMENTS/APPROVALS/UPGRADES, JANUARY 2021-JANUARY 2025
  • TABLE 433 HEALTHCARE ANALYTICS MARKET: DEALS, JANUARY 2021-JANUARY 2025
  • TABLE 434 HEALTHCARE ANALYTICS MARKET: EXPANSIONS, JANUARY 2021-JANUARY 2025
  • TABLE 435 MERATIVE: COMPANY OVERVIEW
  • TABLE 436 MERATIVE: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 437 MERATIVE: PRODUCT/SOLUTION LAUNCHES/ENHANCEMENTS/APPROVALS/UPGRADES, JANUARY 2021-JANUARY 2025
  • TABLE 438 MERATIVE: DEALS, JANUARY 2021-JANUARY 2025
  • TABLE 439 SAS INSTITUTE INC.: COMPANY OVERVIEW
  • TABLE 440 SAS INSTITUTE INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 441 SAS INSTITUTE INC.: PRODUCT/SOLUTION LAUNCHES/ ENHANCEMENTS/ APPROVALS/UPGRADES, JANUARY 2021-JANUARY 2025
  • TABLE 442 OPTUM, INC.: COMPANY OVERVIEW
  • TABLE 443 OPTUM, INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 444 OPTUM, INC.: DEALS, JANUARY 2021-JANUARY 2025
  • TABLE 445 ORACLE: COMPANY OVERVIEW
  • TABLE 446 ORACLE: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 447 ORACLE: PRODUCT/SOLUTION LAUNCHES/ENHANCEMENTS/APPROVALS/UPGRADES, JANUARY 2021-JANUARY 2025
  • TABLE 448 ORACLE: DEALS, JANUARY 2021-JANUARY 2025
  • TABLE 449 ORACLE: EXPANSIONS, JANUARY 2021-JANUARY 2025
  • TABLE 450 VERADIGM LLC: COMPANY OVERVIEW
  • TABLE 451 VERADIGM LLC: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 452 VERADIGM LLC: PRODUCT/SOLUTION LAUNCHES/ENHANCEMENTS/APPROVALS/ UPGRADES, JANUARY 2021-JANUARY 2025
  • TABLE 453 VERADIGM LLC: DEALS, JANUARY 2021-JANUARY 2025
  • TABLE 454 VERADIGM LLC: EXPANSIONS, JANUARY 2021-JANUARY 2025
  • TABLE 455 VERADIGM LLC: OTHER DEVELOPMENTS, JANUARY 2021-JANUARY 2025
  • TABLE 456 EXLSERVICE HOLDINGS, INC.: COMPANY OVERVIEW
  • TABLE 457 EXLSERVICE HOLDINGS, INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 458 EXLSERVICE HOLDINGS, INC.: PRODUCT SOLUTION LAUNCHES/ENHANCEMENTS/ APPROVALS/UPGRADES, JANUARY 2021-JANUARY 2025
  • TABLE 459 EXLSERVICE HOLDINGS, INC.: DEALS, JANUARY 2021-JANUARY 2025
  • TABLE 460 EXLSERVICE HOLDINGS, INC.: OTHER DEVELOPMENTS, JANUARY 2021-JANUARY 2025
  • TABLE 461 CITIUSTECH INC.: COMPANY OVERVIEW
  • TABLE 462 CITIUSTECH INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 463 CITIUSTECH INC.: PRODUCT/SOLUTION LAUNCHES/ENHANCEMENTS/APPROVALS/ UPGRADES, JANUARY 2021-JANUARY 2025
  • TABLE 464 CITIUSTECH INC.: DEALS, JANUARY 2021-JANUARY 2025
  • TABLE 465 CITIUSTECH INC.: OTHER DEVELOPMENTS, JANUARY 2021-JANUARY 2025
  • TABLE 466 CITIUSTECH INC.: OTHER DEVELOPMENTS, JANUARY 2021-JANUARY 2025
  • TABLE 467 HEALTH CATALYST: COMPANY OVERVIEW
  • TABLE 468 HEALTH CATALYST: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 469 HEALTH CATALYST: PRODUCT SOLUTION LAUNCHES/ENHANCEMENTS/APPROVALS/ UPGRADES, JANUARY 2021-JANUARY 2025
  • TABLE 470 HEALTH CATALYST: DEALS, JANUARY 2021-JANUARY 2025
  • TABLE 471 CVS HEALTH: COMPANY OVERVIEW
  • TABLE 472 CVS HEALTH: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 473 CVS HEALTH: DEALS, JANUARY 2021-JANUARY 2025
  • TABLE 474 INOVALON: COMPANY OVERVIEW
  • TABLE 475 INOVALON: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 476 INOVALON: PRODUCT/SOLUTION LAUNCHES/ENHANCEMENTS/APPROVALS/UPGRADES, JANUARY 2021-JANUARY 2025
  • TABLE 477 INOVALON: DEALS, JANUARY 2021-JANUARY 2025
  • TABLE 478 INOVALON: EXPANSIONS, JANUARY 2021-JANUARY 2025
  • TABLE 479 INOVALON: OTHER DEVELOPMENTS, JANUARY 2021-JANUARY 2025
  • TABLE 480 MCKESSON CORPORATION: COMPANY OVERVIEW
  • TABLE 481 MCKESSON CORPORATION: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 482 MCKESSON CORPORATION: DEALS, JANUARY 2021-JANUARY 2025
  • TABLE 483 MEDEANALYTICS, INC.: COMPANY OVERVIEW
  • TABLE 484 MEDEANALYTICS, INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 485 MEDEANALYTICS, INC.: DEALS, JANUARY 2021-JANUARY 2025
  • TABLE 486 MEDEANALYTICS, INC.: OTHER DEVELOPMENTS, JANUARY 2021-JANUARY 2025
  • TABLE 487 COTIVITI, INC.: COMPANY OVERVIEW
  • TABLE 488 COTIVITI, INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 489 COTIVITI, INC.: PRODUCT/SOLUTION LAUNCHES/ENHANCEMENTS/APPROVALS/ UPGRADES, JANUARY 2021-JANUARY 2025
  • TABLE 490 COTIVITI, INC.: OTHER DEVELOPMENTS, JANUARY 2021-JANUARY 2025
  • TABLE 491 APIXIO, INC.: COMPANY OVERVIEW
  • TABLE 492 APIXIO, INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 493 APIXIO, INC.: PRODUCT/SOLUTION LAUNCHES/ENHANCEMENTS/APPROVALS/ UPGRADES, JANUARY 2021-JANUARY 2025
  • TABLE 494 APIXIO, INC.: DEALS, JANUARY 2021-JANUARY 2025
  • TABLE 495 ENLITIC: COMPANY OVERVIEW
  • TABLE 496 ENLITIC: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 497 ENLITIC: PRODUCT/SOLUTION LAUNCHES/ENHANCEMENTS/APPROVALS/UPGRADES, JANUARY 2021-JANUARY 2025
  • TABLE 498 ENLITIC: DEALS, JANUARY 2021-JANUARY 2025
  • TABLE 499 KOMODO HEALTH, INC.: COMPANY OVERVIEW
  • TABLE 500 KOMODO HEALTH, INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 501 KOMODO HEALTH, INC.: PRODUCT/SOLUTION LAUNCHES/ENHANCEMENTS/ APPROVALS/UPGRADES, JANUARY 2021-JANUARY 2025
  • TABLE 502 KOMODO HEALTH, INC.: DEALS, JANUARY 2021-JANUARY 2025
  • TABLE 503 HEALTHEC, LLC: COMPANY OVERVIEW
  • TABLE 504 HEALTHEC, LLC: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 505 HEALTHEC, LLC: DEALS, JANUARY 2021-JANUARY 2025
  • TABLE 506 IQVIA: COMPANY OVERVIEW
  • TABLE 507 IQVIA: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 508 IQVIA: DEALS, JANUARY 2021-JANUARY 2025
  • TABLE 509 WIPRO: COMPANY OVERVIEW
  • TABLE 510 WIPRO: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 511 ARCADIA SOLUTIONS, LLC.: COMPANY OVERVIEW
  • TABLE 512 EVIDATION HEALTH, INC.: COMPANY OVERVIEW
  • TABLE 513 HEALTHCORUM: COMPANY OVERVIEW
  • TABLE 514 AETION, INC.: COMPANY OVERVIEW
  • TABLE 515 TREDENCE.INC.: COMPANY OVERVIEW
  • TABLE 516 SISENSE LTD.: COMPANY OVERVIEW

List of Figures

  • FIGURE 1 HEALTHCARE ANALYTICS MARKET SEGMENTATION AND REGIONAL SCOPE
  • FIGURE 2 HEALTHCARE ANALYTICS MARKET: RESEARCH DESIGN
  • FIGURE 3 PRIMARY SOURCES
  • FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS
  • FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 6 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
  • FIGURE 7 SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS
  • FIGURE 8 REVENUE SHARE ANALYSIS ILLUSTRATION OF OPTUM, INC. (2023)
  • FIGURE 9 CAGR PROJECTIONS FROM ANALYSIS OF MARKET DYNAMICS, 2024-2029
  • FIGURE 10 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
  • FIGURE 11 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH
  • FIGURE 12 HEALTHCARE ANALYTICS MARKET: DATA TRIANGULATION METHODOLOGY
  • FIGURE 13 HEALTHCARE ANALYTICS MARKET, BY TYPE, 2024 VS. 2029 (USD MILLION)
  • FIGURE 14 HEALTHCARE ANALYTICS MARKET, BY APPLICATION, 2024 VS. 2029 (USD MILLION)
  • FIGURE 15 HEALTHCARE ANALYTICS MARKET, BY COMPONENT, 2024 VS. 2029 (USD MILLION)
  • FIGURE 16 HEALTHCARE ANALYTICS MARKET, BY END USER, 2024 VS. 2029 (USD MILLION)
  • FIGURE 17 GEOGRAPHICAL SNAPSHOT OF HEALTHCARE ANALYTICS MARKET
  • FIGURE 18 GOVERNMENT INITIATIVES TO INCREASE ELECTRONIC HEALTH RECORD ADOPTION AND INCREASED PRESSURE TO CURB HEALTHCARE COSTS TO PROPEL MARKET
  • FIGURE 19 NORTH AMERICA HELD LARGEST SHARE OF HEALTHCARE ANALYTICS MARKET IN 2023
  • FIGURE 20 INDIA TO WITNESS HIGHEST GROWTH DURING FORECAST PERIOD
  • FIGURE 21 NORTH AMERICA DOMINATED MARKET IN 2023
  • FIGURE 22 INDIA TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD
  • FIGURE 23 HEALTHCARE ANALYTICS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 24 HEALTH EXPENDITURE AS A SHARE OF GDP, 2022 (OR NEAREST YEAR)
  • FIGURE 25 HEALTHCARE SECURITY BREACHES OF 500+ RECORDS, 2009-2023
  • FIGURE 26 INDIVIDUALS AFFECTED BY HEALTHCARE SECURITY BREACHES, 2009-2023
  • FIGURE 27 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
  • FIGURE 28 HEALTHCARE ANALYTICS MARKET: ECOSYSTEM ANALYSIS
  • FIGURE 29 HEALTHCARE ANALYTICS MARKET: VALUE CHAIN ANALYSIS
  • FIGURE 30 HEALTHCARE ANALYTICS MARKET: PORTER'S FIVE FORCES ANALYSIS
  • FIGURE 31 HEALTHCARE ANALYTICS MARKET: PATENT ANALYSIS, JANUARY 2015-JANUARY 2025
  • FIGURE 32 INFLUENCE OF STAKEHOLDERS IN BUYING PROCESS FOR END USERS
  • FIGURE 33 KEY BUYING CRITERIA FOR END USERS
  • FIGURE 35 MARKET POTENTIAL OF AI/GEN AI IN ENHANCING HEALTHCARE ANALYTICS ACROSS INDUSTRIES
  • FIGURE 36 IMPACT OF AI/GEN AI ON INTERCONNECTED AND ADJACENT ECOSYSTEMS
  • FIGURE 37 NORTH AMERICA: HEALTHCARE ANALYTICS MARKET SNAPSHOT
  • FIGURE 38 ASIA PACIFIC: HEALTHCARE ANALYTICS MARKET SNAPSHOT
  • FIGURE 39 HEALTHCARE ANALYTICS MARKET: REVENUE ANALYSIS OF KEY PLAYERS, 2019-2023
  • FIGURE 40 HEALTHCARE ANALYTICS MARKET: MARKET SHARE ANALYSIS, 2023
  • FIGURE 41 EV/EBITDA OF KEY VENDORS, 2024
  • FIGURE 42 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF HEALTHCARE ANALYTICS VENDORS, 2024
  • FIGURE 43 HEALTHCARE ANALYTICS MARKET: BRAND/SOFTWARE COMPARISON
  • FIGURE 44 HEALTHCARE ANALYTICS MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023
  • FIGURE 45 HEALTHCARE ANALYTICS MARKET: COMPANY FOOTPRINT
  • FIGURE 46 HEALTHCARE ANALYTICS MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2023
  • FIGURE 47 OPTUM, INC.: COMPANY SNAPSHOT (2023)
  • FIGURE 48 ORACLE: COMPANY SNAPSHOT (2023)
  • FIGURE 49 VERADIGM LLC: COMPANY SNAPSHOT (2021)
  • FIGURE 50 EXLSERVICE HOLDINGS, INC.: COMPANY SNAPSHOT (2023)
  • FIGURE 51 HEALTH CATALYST: COMPANY SNAPSHOT (2023)
  • FIGURE 52 CVS HEALTH: COMPANY SNAPSHOT (2021)
  • FIGURE 53 MCKESSON CORPORATION: COMPANY SNAPSHOT (2023)
  • FIGURE 54 IQVIA: COMPANY SNAPSHOT (2023)
  • FIGURE 55 WIPRO: COMPANY SNAPSHOT (2023)
目次
Product Code: HIT 2180

The global Healthcare analytics market is projected to reach 133.19 billion by 2029 from 44.83 billion in 2024, at a CAGR of 24.3 % from 2024 to 2029. The widespread adoption of Electronic Health Records (EHR) is accelerating the growth of the healthcare analytics market. In North America, approximately 78% of office-based physicians and 96% of non-federal acute care hospitals use EHR systems, which are supported by regulatory incentives such as the HITECH Act. Europe has varying adoption rates, with the Netherlands at 97% and an average of 81% across the continent, indicating a high potential for analytics integration. Increased adoption of EHRs improves data accessibility and drives the demand for advanced analytics solutions.

Scope of the Report
Years Considered for the Study2022-2029
Base Year2023
Forecast Period2024-2029
Units ConsideredMillion/Billion (USD)
SegmentsBy Component, Type, Application, and End user
Regions coveredNorth America, Europe, Asia Pacific, Latin America, and Middle East Africa.

"Healthcare analytics , clinical analytics segment to witness the highest growth during the forecast period."

Based on application, the healthcare analytics market is segmented into financial analytics, clinical analytics, operations & administrative analytics and population health analytics. The clinical analytics segment held the largest market share in 2023. Value-Based Care, technological advancements, and improved patient outcomes drive clinical analytics growth by focusing on outcome-based performance, optimizing costs, and enabling personalized, data-driven care through AI and EHR systems. This enhances care quality and efficiency, boosting the healthcare analytics market.

"APAC is estimated to register the highest CAGR during the forecast period."

In this report, the healthcare analytics market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East and Africa. The healthcare analytics market in APAC is projected to register the highest CAGR rate during the forecast period. The APAC healthcare analytics market is groqing due to affordable medical treatments, such as average cost of bypass surgery in APAC region is approximately USD 4000, compared to USD 30,000 to USD 200,000 in the US. Moreover, government support for medical tourism, healthcare infrastructure investment, IT expansion, and a growing aging population with chronic diseases collectively strengthen the region's position in global healthcare.

In-depth interviews have been conducted with chief executive officers (CEOs), Directors, and other executives from various key organizations operating in the authentication and brand protection marketplace.

  • By Company Type: Tier 1 - 45%, Tier 2 - 35%, and Tier 20%
  • By Designation: C-level Executives - 50%, Directors - 30%, and Others - 20%
  • By Region: North America- 40%, Europe - 35%, Asia Pacific- 20% and RoW- 5%

Merative (US), Optum, Inc.(US), SAS Institute Inc. (US), Oracle (US), Citiustech Inc (US) are some of the key players in the healthcare analytics market.

The study includes an in-depth competitive analysis of these key players in the healthcare analytics market, with their company profiles, recent developments, and key market strategies.

Research Coverage

This research report categorizes the healthcare analytics market by component (Services, Software), by type (Descriptive analytics, Predictive analytics, Prescriptive analytics, Diagnostic analytics), by application (Financial analytics, Clinical analytics, Operations & Administration analytics, Population Health analytics), by end-user (Payers, Providers, Pharmaceutical & Medical device supply chain) and by region (North America, Europe, Asia Pacific, Latin America, and Middle East and Africa). The scope of the report covers detailed information regarding the major factors, such as drivers, restraints, challenges, and opportunities, influencing the growth of the healthcare analytics market. A detailed analysis of the key industry players has been done to provide insights into their business overview, solutions, and services; key strategies; Contracts, partnerships, agreements. new product & service launches, mergers and acquisitions, and recent developments associated with the healthcare analytics market. Competitive analysis of upcoming startups in the healthcare analytics market ecosystem is covered in this report.

Reasons to buy this report

The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the healthcare analytics market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and to plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, challenges, and opportunities.

The report provides insights on the following pointers:

  • Analysis of key drivers (Government initiatives to increase EHR adoption, Growing venture capital investments in healthcare analytics start-ups, Growing pressure to curb healthcare spending and improve patient outcomes, Heterogeneity and complexity of big data in healthcare, Growing focus on real-world evidence, Cost Management and Operational Efficiency, Rise of Telemedicine and Remote Monitoring, Regulatory Compliance and Quality Improvement, Increasing demand for data-driven decision-making), restraints (High cost of analytics solutions in healthcare organizations, Rising data breach concerns), opportunities (Increasing focus on value-based medicines, Use of analytics in precision and personalized medicines, Cloud-based analytics, Increasing number of patient registries, Emergence of social media and its impact on healthcare industry, Augmented analytics to supplement human intelligence, Analytics of healthcare things), and challenges (Concerns regarding inaccurate and inconsistent data, Reluctance to adopt healthcare analytics solutions in emerging countries, Data integration for coordinated care, Operational gaps between payers and providers, Dearth of skilled personnel) influencing the growth of the healthcare analytics market
  • Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product & service launches in the healthcare analytics market
  • Market Development: Comprehensive information about lucrative markets - the report analyses the healthcare analytics market across varied regions.
  • Market Diversification: Exhaustive information about new products & services, untapped geographies, recent developments, and investments in the healthcare analytics market
  • Competitive Assessment: In-depth assessment of market shares, growth strategies and service offerings of leading players like Merative (US), Optum, Inc.(US), SAS Institute Inc. (US), Oracle (US), Citiustech Inc (US), Inovalon (US), Mckesson Corporation (US), MedeAnalytics, Inc.(US), Cotiviti, Inc. (US), Exlservice Holdings, Inc. (US), Wipro (India), Apixio. (US); among others in healthcare analytics market

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 STUDY OBJECTIVES
  • 1.2 MARKET DEFINITION
  • 1.3 STUDY SCOPE
    • 1.3.1 MARKETS COVERED AND REGIONAL SCOPE
    • 1.3.2 INCLUSIONS AND EXCLUSIONS
    • 1.3.3 YEARS CONSIDERED
  • 1.4 CURRENCY CONSIDERED
  • 1.5 STAKEHOLDERS
  • 1.6 SUMMARY OF CHANGES
  • 1.7 IMPACT OF AI/GEN AI

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH APPROACH
    • 2.1.1 SECONDARY DATA
      • 2.1.1.1 Key data from secondary sources
    • 2.1.2 PRIMARY DATA
      • 2.1.2.1 Key data from primary sources
      • 2.1.2.2 Insights from primary experts
  • 2.2 RESEARCH METHODOLOGY DESIGN
  • 2.3 MARKET SIZE ESTIMATION METHODOLOGY
  • 2.4 MARKET BREAKDOWN AND DATA TRIANGULATION
  • 2.5 RESEARCH ASSUMPTIONS
  • 2.6 RESEARCH LIMITATIONS
    • 2.6.1 METHODOLOGY-RELATED LIMITATIONS
    • 2.6.2 SCOPE-RELATED LIMITATIONS
  • 2.7 RISK ASSESSMENT

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

  • 4.1 HEALTHCARE ANALYTICS MARKET OVERVIEW
  • 4.2 NORTH AMERICA: HEALTHCARE ANALYTICS MARKET SHARE, BY END USER AND COUNTRY (2023)
  • 4.3 HEALTHCARE ANALYTICS MARKET, BY COUNTRY
  • 4.4 HEALTHCARE ANALYTICS MARKET: REGIONAL MIX
  • 4.5 HEALTHCARE ANALYTICS MARKET: EMERGING ECONOMIES VS. DEVELOPED COUNTRIES

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • 5.2.1 DRIVERS
      • 5.2.1.1 Favorable government initiatives for electronic health record adoption
      • 5.2.1.2 Growing venture capital investments in startups
      • 5.2.1.3 Need to reduce healthcare costs
      • 5.2.1.4 Increasing focus on real-world evidence
      • 5.2.1.5 Rise of telemedicine and remote patient monitoring
      • 5.2.1.6 Growing focus on regulatory compliance
    • 5.2.2 RESTRAINTS
      • 5.2.2.1 High cost of analytics solutions
      • 5.2.2.2 Growing concerns about data breach
    • 5.2.3 OPPORTUNITIES
      • 5.2.3.1 Increasing focus on value-based medicines
      • 5.2.3.2 Growing use of analytics in healthcare
      • 5.2.3.3 Rising number of patient registries
      • 5.2.3.4 Emergence of social media and digital health technologies
    • 5.2.4 CHALLENGES
      • 5.2.4.1 Concerns regarding inaccurate and inconsistent data
      • 5.2.4.2 Reluctance to adopt healthcare analytics solutions in developing countries
      • 5.2.4.3 Lack of maintenance of medical records
      • 5.2.4.4 Shortage of skilled personnel
  • 5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
  • 5.4 INDUSTRY TRENDS
    • 5.4.1 INCREASING PARTNERSHIPS AND COLLABORATIONS AMONG MARKET PLAYERS
    • 5.4.2 SHIFT OF RISK BURDEN FROM PAYERS TO PROVIDERS
    • 5.4.3 GROWING ADOPTION OF CLOUD-BASED IT SOLUTIONS
  • 5.5 ECOSYSTEM ANALYSIS
  • 5.6 VALUE CHAIN ANALYSIS
  • 5.7 TECHNOLOGY ANALYSIS
    • 5.7.1 KEY TECHNOLOGIES
      • 5.7.1.1 Big data analytics
      • 5.7.1.2 Artificial intelligence and machine learning
      • 5.7.1.3 Business intelligence tools
    • 5.7.2 ADJACENT TECHNOLOGIES
      • 5.7.2.1 Cloud computing
      • 5.7.2.2 Internet of things
  • 5.8 REGULATORY ANALYSIS
    • 5.8.1 REGULATORY LANDSCAPE
    • 5.8.2 GOVERNMENT REGULATIONS
      • 5.8.2.1 US
      • 5.8.2.2 Europe
      • 5.8.2.3 China
      • 5.8.2.4 Japan
      • 5.8.2.5 India
    • 5.8.3 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • 5.9 PRICING ANALYSIS
    • 5.9.1 AVERAGE SELLING PRICE OF HEALTHCARE ANALYTICS SOLUTIONS, BY COMPONENT
    • 5.9.2 AVERAGE SELLING PRICE, BY REGION
  • 5.10 PORTER'S FIVE FORCES ANALYSIS
  • 5.11 PATENT ANALYSIS
  • 5.12 KEY STAKEHOLDERS AND BUYING CRITERIA
    • 5.12.1 KEY STAKEHOLDERS IN BUYING PROCESS
    • 5.12.2 BUYING CRITERIA
  • 5.13 END-USER ANALYSIS
    • 5.13.1 UNMET NEEDS
    • 5.13.2 END-USER EXPECTATIONS
  • 5.14 KEY CONFERENCES AND EVENTS, 2024-2025
  • 5.15 CASE STUDY ANALYSIS
  • 5.16 BUSINESS MODEL ANALYSIS
  • 5.17 INVESTMENT AND FUNDING SCENARIO
  • 5.18 IMPACT OF AI/GEN AI ON HEALTHCARE ANALYTICS MARKET
    • 5.18.1 KEY USE CASES
    • 5.18.2 CASE STUDY ON AI/GEN AI
    • 5.18.3 ADJACENT MARKET ECOSYSTEM
      • 5.18.3.1 Life science analytics market
      • 5.18.3.2 Healthcare IT market
      • 5.18.3.3 Healthcare fraud analytics market
    • 5.18.4 USER READINESS AND IMPACT ASSESSMENT
      • 5.18.4.1 User readiness
        • 5.18.4.1.1 Payers
        • 5.18.4.1.2 Providers
      • 5.18.4.2 Impact assessment
        • 5.18.4.2.1 User A: Payers
          • 5.18.4.2.1.1 Implementation
          • 5.18.4.2.1.2 Impact
        • 5.18.4.2.2 User B: Providers
          • 5.18.4.2.2.1 Implementation
          • 5.18.4.2.2.2 Impact

6 HEALTHCARE ANALYTICS MARKET, BY COMPONENT

  • 6.1 INTRODUCTION
  • 6.2 SERVICES
    • 6.2.1 MANAGED SERVICES
      • 6.2.1.1 Analytical services
        • 6.2.1.1.1 Increasing volume of healthcare data to facilitate growth
      • 6.2.1.2 Consulting services
        • 6.2.1.2.1 Need to improve clinical outcomes and patient satisfaction to support growth
    • 6.2.2 PROFESSIONAL SERVICES
      • 6.2.2.1 Training & implementation services
        • 6.2.2.1.1 Growing emphasis on value-based care and specialized training services to drive market
      • 6.2.2.2 Maintenance & support services
        • 6.2.2.2.1 Expanding research needs to propel demand for maintenance & support services
  • 6.3 SOFTWARE
    • 6.3.1 ON-PREMISE SOFTWARE
      • 6.3.1.1 Provision of multi-vendor architecture and security benefits to drive market
    • 6.3.2 CLOUD-BASED SOFTWARE
      • 6.3.2.1 Real-time analysis and elimination of purchasing costs for software & hardware to drive adoption

7 HEALTHCARE ANALYTICS MARKET, BY TYPE

  • 7.1 INTRODUCTION
  • 7.2 DESCRIPTIVE ANALYTICS
    • 7.2.1 INCREASING USE IN PATIENT POPULATION MANAGEMENT AND FINANCIAL MANAGEMENT TO BOOST MARKET
  • 7.3 PREDICTIVE ANALYTICS
    • 7.3.1 ABILITY OF PREDICTIVE ANALYTICS TO HELP HEALTHCARE ORGANIZATIONS AVOID PREVENTABLE EVENTS TO SUPPORT GROWTH
  • 7.4 PRESCRIPTIVE ANALYTICS
    • 7.4.1 NEED FOR BETTER TREATMENT METHODS AND BUSINESS PRACTICES TO ENCOURAGE GROWTH
  • 7.5 DIAGNOSTIC ANALYTICS
    • 7.5.1 RISE IN LAUNCHES OF AI-DRIVEN ANALYTICS PRODUCTS AND SERVICES TO EXPEDITE GROWTH

8 HEALTHCARE ANALYTICS MARKET, BY APPLICATION

  • 8.1 INTRODUCTION
  • 8.2 FINANCIAL ANALYTICS
    • 8.2.1 CLAIMS PROCESSING
      • 8.2.1.1 Increasing shift from paper-based claims processing to electronic mode to augment growth
    • 8.2.2 REVENUE CYCLE MANAGEMENT
      • 8.2.2.1 Growing focus on financial forecasting and budgeting process to boost market
    • 8.2.3 PAYMENT INTEGRITY & FRAUD, WASTE, AND ABUSE
      • 8.2.3.1 Implementation of ICD-10 code sets and adoption of fee-for-value systems to drive market
    • 8.2.4 RISK ADJUSTMENT & ASSESSMENT
      • 8.2.4.1 Rise in special enrollment periods and new subsidies to accelerate growth
  • 8.3 CLINICAL ANALYTICS
    • 8.3.1 QUALITY IMPROVEMENT & CLINICAL BENCHMARKING
      • 8.3.1.1 Growing adoption of benchmarking to identify negative issues impacting healthcare systems to drive market
    • 8.3.2 CLINICAL DECISION SUPPORT
      • 8.3.2.1 Need to reduce medical errors and expedite diagnosis to boost market
    • 8.3.3 REPORTING & COMPLIANCE
      • 8.3.3.1 Ability to track regulatory changes, assess non-compliance, and perform internal audits to sustain growth
    • 8.3.4 COMPARATIVE ANALYTICS/EFFECTIVENESS
      • 8.3.4.1 Growing adoption of electronic health records to fuel market
    • 8.3.5 PRECISION HEALTH/REAL-WORLD EVIDENCE
      • 8.3.5.1 Strong government support for personalized medicine to sustain growth
    • 8.3.6 MEDICAL IMAGING ANALYTICS
      • 8.3.6.1 Ability to provide real-time insights and diagnosis of genetic disorders to aid growth
  • 8.4 OPERATIONAL & ADMINISTRATIVE ANALYTICS
    • 8.4.1 SUPPLY CHAIN ANALYTICS
      • 8.4.1.1 Growing need to reduce healthcare costs and implement better inventory management practices to fuel market
    • 8.4.2 WORKFORCE ANALYTICS
      • 8.4.2.1 Need for effective recruitment to favor growth
    • 8.4.3 STRATEGIC ANALYTICS
      • 8.4.3.1 Growing use of advanced analytics tools for geographic expansion and service line expansion to drive market
  • 8.5 POPULATION HEALTH ANALYTICS
    • 8.5.1 RISING USE IN CLINICAL OUTCOME ENGAGEMENT AND POPULATION RISK MANAGEMENT TO SPUR GROWTH

9 HEALTHCARE ANALYTICS MARKET, BY END USER

  • 9.1 INTRODUCTION
  • 9.2 PAYERS
    • 9.2.1 PRIVATE INSURANCE COMPANIES
      • 9.2.1.1 Increasing reliance on analytics for fraud prevention and claims processing to contribute to growth
    • 9.2.2 GOVERNMENT AGENCIES
      • 9.2.2.1 Rising use of analytics solutions to maximize payment accuracy and set reimbursement rates to boost market
  • 9.3 PROVIDERS
    • 9.3.1 HOSPITALS & CLINICS
      • 9.3.1.1 Growing adoption of healthcare analytics solutions by large hospitals, medical groups, and physician practices to boost market
    • 9.3.2 POST-ACUTE CARE ORGANIZATIONS
      • 9.3.2.1 Increasing use of analytics solutions to review and study patient data to drive market
    • 9.3.3 AMBULATORY SURGERY CENTERS
      • 9.3.3.1 Need to control healthcare costs to support market
    • 9.3.4 OTHER PROVIDERS
  • 9.4 PHARMACEUTICAL & MEDICAL DEVICE SUPPLY CHAIN
    • 9.4.1 MANUFACTURERS
      • 9.4.1.1 Growing adoption of digital technologies to drive market
    • 9.4.2 DISTRIBUTORS & WHOLESALERS
      • 9.4.2.1 Need for improved supply chain operations, inventory management, and service delivery to boost market
    • 9.4.3 RETAILERS
      • 9.4.3.1 Rising integration of healthcare analytics into retail operations to stimulate growth

10 HEALTHCARE ANALYTICS MARKET, BY REGION

  • 10.1 INTRODUCTION
  • 10.2 NORTH AMERICA
    • 10.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
    • 10.2.2 US
      • 10.2.2.1 High adoption of electronic health records to drive market
    • 10.2.3 CANADA
      • 10.2.3.1 Need for managing patient volumes, clinical data, and healthcare costs to favor market
  • 10.3 EUROPE
    • 10.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
    • 10.3.2 GERMANY
      • 10.3.2.1 Government initiatives to increase use of analytics in healthcare
    • 10.3.3 UK
      • 10.3.3.1 Availability of venture capital investments to drive market
    • 10.3.4 FRANCE
      • 10.3.4.1 Strong financial support for digital health to augment market
    • 10.3.5 ITALY
      • 10.3.5.1 Growing number of drug approvals to drive uptake of analytics solutions
    • 10.3.6 SPAIN
      • 10.3.6.1 Growing adoption of personalized medicine to drive market
    • 10.3.7 REST OF EUROPE
  • 10.4 ASIA PACIFIC
    • 10.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
    • 10.4.2 JAPAN
      • 10.4.2.1 Rising geriatric population to drive demand for effective patient management solutions
    • 10.4.3 CHINA
      • 10.4.3.1 Favorable reforms and growing number of electronic health records to aid growth
    • 10.4.4 INDIA
      • 10.4.4.1 Favorable government initiatives to fuel market
    • 10.4.5 REST OF ASIA PACIFIC
  • 10.5 LATIN AMERICA
    • 10.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
    • 10.5.2 BRAZIL
      • 10.5.2.1 Growing adoption of digital solutions in healthcare to boost market
    • 10.5.3 MEXICO
      • 10.5.3.1 Growing prominence of startups and rising R&D activity to propel market
    • 10.5.4 REST OF LATIN AMERICA
  • 10.6 MIDDLE EAST & AFRICA
    • 10.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
    • 10.6.2 GCC COUNTRIES
      • 10.6.2.1 Rising investments, advancements, and developing healthcare infrastructure to drive market
    • 10.6.3 REST OF MIDDLE EAST & AFRICA

11 COMPETITIVE LANDSCAPE

  • 11.1 INTRODUCTION
  • 11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN, 2021-2025
  • 11.3 REVENUE ANALYSIS, 2019-2023
  • 11.4 MARKET SHARE ANALYSIS, 2023
  • 11.5 COMPANY EVALUATION AND FINANCIAL METRICS
  • 11.6 BRAND/SOFTWARE COMPARISON
  • 11.7 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
    • 11.7.1 STARS
    • 11.7.2 EMERGING LEADERS
    • 11.7.3 PERVASIVE PLAYERS
    • 11.7.4 PARTICIPANTS
    • 11.7.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023
      • 11.7.5.1 Company footprint
      • 11.7.5.2 Region footprint
      • 11.7.5.3 Component footprint
      • 11.7.5.4 Application footprint
      • 11.7.5.5 End-user footprint
  • 11.8 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023
    • 11.8.1 PROGRESSIVE COMPANIES
    • 11.8.2 RESPONSIVE COMPANIES
    • 11.8.3 DYNAMIC COMPANIES
    • 11.8.4 STARTING BLOCKS
    • 11.8.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023
      • 11.8.5.1 Detailed list of key startups/SMEs
      • 11.8.5.2 Competitive benchmarking of key startups/SMEs
  • 11.9 COMPETITIVE SCENARIO
    • 11.9.1 PRODUCT/SOLUTION LAUNCHES/ENHANCEMENTS/APPROVALS/ UPGRADES
    • 11.9.2 DEALS
    • 11.9.3 EXPANSIONS

12 COMPANY PROFILES

  • 12.1 KEY PLAYERS
    • 12.1.1 MERATIVE
      • 12.1.1.1 Business overview
      • 12.1.1.2 Products/Solutions/Services offered
      • 12.1.1.3 Recent developments
        • 12.1.1.3.1 Product/Solution launches/enhancements/approvals/ upgrades
        • 12.1.1.3.2 Deals
      • 12.1.1.4 MnM view
        • 12.1.1.4.1 Key strengths
        • 12.1.1.4.2 Strategic choices
        • 12.1.1.4.3 Weaknesses and competitive threats
    • 12.1.2 SAS INSTITUTE INC.
      • 12.1.2.1 Business overview
      • 12.1.2.2 Products/Solutions/Services offered
      • 12.1.2.3 Recent developments
        • 12.1.2.3.1 Product/Solution launches/enhancements/approvals/ upgrades
      • 12.1.2.4 MnM view
        • 12.1.2.4.1 Key strengths
        • 12.1.2.4.2 Strategic choices
        • 12.1.2.4.3 Weaknesses and competitive threats
    • 12.1.3 OPTUM, INC.
      • 12.1.3.1 Business overview
      • 12.1.3.2 Products/Solutions/Services offered
      • 12.1.3.3 Recent developments
        • 12.1.3.3.1 Deals
      • 12.1.3.4 MnM view
        • 12.1.3.4.1 Key strengths
        • 12.1.3.4.2 Strategic choices
        • 12.1.3.4.3 Weaknesses and competitive threats
    • 12.1.4 ORACLE
      • 12.1.4.1 Business overview
      • 12.1.4.2 Products/Solutions/Services offered
      • 12.1.4.3 Recent developments
        • 12.1.4.3.1 Product/Solution launches/enhancements/approvals/ upgrades
        • 12.1.4.3.2 Deals
        • 12.1.4.3.3 Expansions
      • 12.1.4.4 MnM view
        • 12.1.4.4.1 Key strengths
        • 12.1.4.4.2 Strategic choices
        • 12.1.4.4.3 Weaknesses and competitive threats
    • 12.1.5 VERADIGM LLC
      • 12.1.5.1 Business overview
      • 12.1.5.2 Products/Solutions/Services offered
      • 12.1.5.3 Recent developments
        • 12.1.5.3.1 Product/Solution launches/enhancements/approvals/ upgrades
        • 12.1.5.3.2 Deals
        • 12.1.5.3.3 Expansions
        • 12.1.5.3.4 Other developments
      • 12.1.5.4 MnM view
        • 12.1.5.4.1 Key strengths
        • 12.1.5.4.2 Strategic choices
        • 12.1.5.4.3 Weaknesses and competitive threats
    • 12.1.6 EXLSERVICE HOLDINGS, INC.
      • 12.1.6.1 Business overview
      • 12.1.6.2 Products/Solutions/Services offered
      • 12.1.6.3 Recent developments
        • 12.1.6.3.1 Product/Solution launches/enhancements/approvals/ upgrades
        • 12.1.6.3.2 Deals
        • 12.1.6.3.3 Other developments
    • 12.1.7 CITIUSTECH INC.
      • 12.1.7.1 Business overview
      • 12.1.7.2 Products/Solutions/Services offered
      • 12.1.7.3 Recent developments
        • 12.1.7.3.1 Product/Solution launches/enhancements/approvals/ upgrades
        • 12.1.7.3.2 Deals
        • 12.1.7.3.3 Expansions
        • 12.1.7.3.4 Other developments
    • 12.1.8 HEALTH CATALYST
      • 12.1.8.1 Business overview
      • 12.1.8.2 Products/Solutions/Services offered
      • 12.1.8.3 Recent developments
        • 12.1.8.3.1 Product/Solution launches/enhancements/approvals/ upgrades
        • 12.1.8.3.2 Deals
    • 12.1.9 CVS HEALTH
      • 12.1.9.1 Business overview
      • 12.1.9.2 Products/Solutions/Services offered
      • 12.1.9.3 Recent developments
        • 12.1.9.3.1 Deals
    • 12.1.10 INOVALON
      • 12.1.10.1 Business overview
      • 12.1.10.2 Products/Solutions/Services offered
      • 12.1.10.3 Recent developments
        • 12.1.10.3.1 Product/Solution launches/enhancements/approvals/ upgrades
        • 12.1.10.3.2 Deals
        • 12.1.10.3.3 Expansions
        • 12.1.10.3.4 Other developments
    • 12.1.11 MCKESSON CORPORATION
      • 12.1.11.1 Business overview
      • 12.1.11.2 Products/Solutions/Services offered
      • 12.1.11.3 Recent developments
        • 12.1.11.3.1 Deals
    • 12.1.12 MEDEANALYTICS, INC.
      • 12.1.12.1 Business overview
      • 12.1.12.2 Products/Solutions/Services offered
      • 12.1.12.3 Recent developments
        • 12.1.12.3.1 Deals
        • 12.1.12.3.2 Other developments
    • 12.1.13 COTIVITI, INC.
      • 12.1.13.1 Business overview
      • 12.1.13.2 Products/Solutions/Services offered
      • 12.1.13.3 Recent developments
        • 12.1.13.3.1 Product/Solution launches/enhancements/approvals/ upgrades
        • 12.1.13.3.2 Other developments
    • 12.1.14 APIXIO, INC.
      • 12.1.14.1 Business overview
      • 12.1.14.2 Products/Solutions/Services offered
      • 12.1.14.3 Recent developments
        • 12.1.14.3.1 Product/Solution launches/enhancements/approvals/ upgrades
        • 12.1.14.3.2 Deals
    • 12.1.15 ENLITIC
      • 12.1.15.1 Business overview
      • 12.1.15.2 Products/Solutions/Services offered
      • 12.1.15.3 Recent developments
        • 12.1.15.3.1 Product/Solution launches/enhancements/approvals/ upgrades
        • 12.1.15.3.2 Deals
    • 12.1.16 KOMODO HEALTH, INC.
      • 12.1.16.1 Business overview
      • 12.1.16.2 Products/Solutions/Services offered
      • 12.1.16.3 Recent developments
        • 12.1.16.3.1 Product/Solution launches/enhancements/approvals/ upgrades
        • 12.1.16.3.2 Deals
    • 12.1.17 HEALTHEC, LLC
      • 12.1.17.1 Business overview
      • 12.1.17.2 Products/Solutions/Services offered
      • 12.1.17.3 Recent developments
        • 12.1.17.3.1 Deals
    • 12.1.18 IQVIA
      • 12.1.18.1 Business overview
      • 12.1.18.2 Products/Solutions/Services offered
      • 12.1.18.3 Recent developments
        • 12.1.18.3.1 Deals
    • 12.1.19 WIPRO
      • 12.1.19.1 Business overview
      • 12.1.19.2 Products/Solutions/Services offered
  • 12.2 OTHER PLAYERS
    • 12.2.1 ARCADIA SOLUTIONS, LLC.
    • 12.2.2 EVIDATION HEALTH, INC.
    • 12.2.3 HEALTHCORUM
    • 12.2.4 AETION, INC.
    • 12.2.5 TREDENCE.INC.
    • 12.2.6 SISENSE LTD.

13 APPENDIX

  • 13.1 DISCUSSION GUIDE
  • 13.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 13.3 CUSTOMIZATION OPTIONS
  • 13.4 RELATED REPORTS
  • 13.5 AUTHOR DETAILS